Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is EuroEyes International Eye Clinic PS Ratio?
EuroEyes International Eye ClinicHKSE:01846 +0.42%81 PS Ratio is 0.96 as of Sep. 02, 2026, which is 65% below its 10-year median of 2.78. GuruFocus rates HKSE:01846 with a GF Score™ of 81/100 and a GF Value™ of HK$5.61 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 661 Healthcare Providers & Services companies, EuroEyes International Eye Clinic ranks better than 65.81% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, EuroEyes International Eye Clinic's share price is HK$2.38.
EuroEyes International Eye Clinic's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2.49. Hence, EuroEyes International Eye Clinic's PS Ratio for today is 0.96.
Good Sign:
EuroEyes International Eye Clinic Ltd stock PS Ratio (=0.96) is close to 10-year low of 0.93.
HKSE:01846'
s PS Ratio Range Over the Past 10 Years
Min: 0.93 Med: 2.78 Max: 11.09
Current: 0.96
During the past 10 years, EuroEyes International Eye Clinic's highest PS Ratio was 11.09. The lowest was 0.93. And the median was 2.78.
HKSE:01846's PS Ratio is ranked better than 65.81% of 661
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs HKSE:01846: 0.96
During the past 10 years, EuroEyes International Eye Clinic's highest 3-Year average Revenue per Share Growth Rate was 29.00% per year. The lowest was 3.10% per year. And the median was 10.70% per year.
EuroEyes International Eye Clinic (HKSE:01846) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
EuroEyes International Eye Clinic PS Ratio Related Terms
EuroEyes International Eye Clinic PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's PS Ratio distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's PS Ratio falls into.
EuroEyes International Eye Clinic PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
EuroEyes International Eye Clinic's Share Price of today is HK$2.38.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EuroEyes International Eye Clinic's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2.49.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
EuroEyes International Eye Clinic (HKSE:01846) has a PS Ratio of 0.96 as of Sep. 02, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on EuroEyes International Eye Clinic and its competitors. This is 65% below median its historical median of 2.78. Over the past decade, EuroEyes International Eye Clinic's PS Ratio has ranged from 0.93 to 11.09. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #226 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 34.2%.
Is EuroEyes International Eye Clinic's PS Ratio too high?
EuroEyes International Eye Clinic's current PS Ratio of 0.96 is 65% below median its 10-year median of 2.78. Over the past 10 years, this metric has ranged from a low of 0.93 to a high of 11.09. The Healthcare Providers & Services industry median PS Ratio is 1.52. EuroEyes International Eye Clinic's value of 0.96 is 36.8% below this industry median. Based on the distribution chart, EuroEyes International Eye Clinic ranks #226 out of 661 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, EuroEyes International Eye Clinic has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #226 out of 661 companies for PS Ratio. This puts EuroEyes International Eye Clinic in the upper half of its industry. The industry median PS Ratio is 1.52. EuroEyes International Eye Clinic's value of 0.96 is 36.8% below this benchmark. Historically, EuroEyes International Eye Clinic's own PS Ratio has ranged from 0.93 to 11.09 over the past decade. While the company's 10-year median is 2.78 vs. the industry median of 1.52, EuroEyes International Eye Clinic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EuroEyes International Eye Clinic's current PS Ratio of 0.96 is 36.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on EuroEyes International Eye Clinic and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current PS Ratio is 0.96, which is 65% below median its own 10-year median of 2.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.61, compared to a current price of HK$2.38 — trading 57.6% below its estimated fair value. The current PS Ratio is 0.96, which is 65% below median its 10-year median of 2.78 and 36.8% below the Healthcare Providers & Services industry median of 1.52. EuroEyes International Eye Clinic's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current PS Ratio is 0.96 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.38 is trading 57.6% below its estimated GF Value™ of HK$5.61.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
PS Ratio: 0.96 (65% below median its 10-year median of 2.78)
GF Value™: HK$5.61 vs. price of HK$2.38 (57.6% below fair value)
Industry Position: 36.8% below the Healthcare Providers & Services median (#226 of 661)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
81GF Score
Get the complete analysis for HKSE:01846
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
